The ripple effects of a restrictive Medicaid formulary

被引：0
|
作者：
Grabowski, H [1 ]
机构：
[1] Duke Univ, Dept Econ, Durham, NC 27708 USA
来源：
AMERICAN JOURNAL OF MANAGED CARE | 2003年 / 9卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R19 [保健组织与事业（卫生事业管理）];
学科分类号：
摘要：
引用
收藏
页码：648 / 649
页数：2
相关论文
共 50 条
  • [1] Impact of Maine's Medicaid drug formulary change on non-Medicaid markets: Spillover effects of a restrictive drug formulary
    Wang, YR
    Pauly, MV
    Lin, YA
    AMERICAN JOURNAL OF MANAGED CARE, 2003, 9 (10): : 686 - 696
  • [2] Impact of a Restrictive Formulary on glycemic control compared with an Open Formulary
    Duong, Tinh
    Jolliff, Jeff
    Duvall, Alan
    Aguirre, Raquel
    Lash, David Benjamin
    JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY, 2024,
  • [3] MEDICAID DRUG FORMULARY RESTRICTIONS
    DRANOVE, D
    JOURNAL OF LAW & ECONOMICS, 1989, 32 (01): : 143 - 162
  • [4] EXPANDING MEDICAID DRUG FORMULARY COVERAGE - EFFECTS ON UTILIZATION OF RELATED SERVICES
    KOZMA, CM
    REEDER, CE
    LINGLE, EW
    MEDICAL CARE, 1990, 28 (10) : 963 - 977
  • [5] THE EFFECTS OF AN INTERNAL ANALGESIC FORMULARY RESTRICTION ON MEDICAID DRUG EXPENDITURES IN WISCONSIN
    KRELING, DH
    KNOCKE, DJ
    HAMMEL, RW
    MEDICAL CARE, 1989, 27 (01) : 34 - 44
  • [6] Choosing drug of choice from restrictive formulary
    Bender, KJ
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 1997, 17 (03) : 145 - 148
  • [7] Medicaid prescription formulary restrictions and arthritis treatment costs
    Johnson, Tricia J.
    Stahl-Moncada, Stephanie
    AMERICAN JOURNAL OF PUBLIC HEALTH, 2008, 98 (07) : 1300 - 1305
  • [8] Spillover effects of restrictive drug formularies on physician prescribing behavior: Evidence from Medicaid
    Wang, YR
    Pauly, MV
    JOURNAL OF ECONOMICS & MANAGEMENT STRATEGY, 2005, 14 (03) : 755 - 773
  • [9] MEDICAID FORMULARY RESTRICTIONS AND EXPENDITURES FOR PATIENTS WITH MAJOR DEPRESSIVE DISORDER
    Seabury, S.
    Lakdawalla, D. N.
    Walter, D.
    Hayes, J.
    Gustafson, T.
    Shrestha, A.
    Goldman, D. P.
    VALUE IN HEALTH, 2014, 17 (03) : A222 - A222
  • [10] UNINTENDED PRESCRIBING CHANGES RESULTING FROM MEDICAID FORMULARY RESTRICTIONS
    SOUMERAI, SB
    ROSSDEGNAN, D
    AVORN, J
    CLINICAL RESEARCH, 1988, 36 (03): : A350 - A350
12345